Androgen receptors are required for full masculinization of nitric oxide synthase system in rat limbic-hypothalamic region.
The neuronal nitric oxide synthase (nNOS) is involved in the control of male and female sexual behavior and its distribution in several regions of the limbic-hypothalamic system, as well as its coexistence with gonadal hormones' receptors, suggests that these hormones may play a significant role in controlling its expression. However, data illustrating the role of gonadal hormones in controlling the nNOS expression are, at present, contradictory, even if they strongly suggest an involvement of testosterone (T) in the regulation of nNOS. The action of T may be mediated through androgen (AR) or, after aromatization to estradiol (E(2)), through estrogen receptors. To elucidate the role of AR on nNOS expression, we compared male and female rats with a non-functional mutation of AR (Tfm, testicular feminization mutation) to their control littermates. We investigated some hypothalamic and limbic nuclei involved in the control of sexual behavior [medial preoptic area (MPA), paraventricular (PVN), arcuate (ARC), ventromedial (VMH) and stria terminalis (BST) nuclei]. In BST (posterior subdivision), VMH (ventral subdivision), and MPA we detected a significant sexual dimorphism in control animals and a decrease of nNOS positive elements in Tfm males compared to their littermate. In addition, we observed a significant increase of nNOS positive elements in BST (posterior) of Tfm females. No significant changes were observed in the other nuclei. These data indicate that, contrary to current opinions, androgens, through the action of AR may have a relevant role in the organization and modulation of the nNOS hypothalamic system.
Martini
M
M
Laboratory of Neuroendocrinology, Department of Anatomy, Pharmacology and Forensic Medicine, Neuroscience Institute of Turin (NIT), University of Torino, Torino, Italy.
Di Sante
G
G
Collado
P
P
Pinos
H
H
Guillamon
A
A
Panzica
G C
GC
D013734:Androgen-Insensitivity Syndrome / Q000235:genetics / Q000378:metabolism; D000728:Androgens / Q000502:physiology; D000818:Animals; D030801:Animals, Genetically Modified; D005260:Female; D007031:Hypothalamus / Q000378:metabolism*; D008032:Limbic System / Q000378:metabolism* / Q000502:physiology; D008297:Male; D008954:Models, Biological; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D011944:Receptors, Androgen / Q000378:metabolism / Q000502:physiology*; D012733:Sex Differentiation / Q000502:physiology; D014770:Virilism / Q000378:metabolism*
D000728:Androgens; D011944:Receptors, Androgen; D052248:Nitric Oxide Synthase Type I